Cardiologists have always been the initial adopters of the home sleep device as well as telemedicine applications. They are aware of the drawbacks of in-lab sleep testing which is also known as polysomnography. The PSG tests which began in 1970 in a sleep clinic set up at the Stanford University can cause patients to undergo discomfort because of the many intrusive wires and tubes and the expense which is high even when part of the costs are covered by insurance companies of the patient. Moreover, it was also difficult to get the results of in lab tests at the scheduled time causing a delay for offering patients with the treatment they needed after undergoing preventive diagnosis.
The home sleep device became popular in March 2008 when the Centers for Medicare and Medicaid released a proposed decision for the modification of national coverage determination policy pertaining to the coverage of CPAP for adult obstructive sleep apnea. The modification allowed for an initial 12 week period of CPAP coverage when obstructive sleep apnea was diagnosed after considering unattended home sleep testing.
The home sleep device is the ideal solution for cardiologists as confirmed by Prof. David Vorchheimer, director of clinical cardiology at the NYC academic Medical Center and numerous others who have utilized the devices on patients that were suffering from sleep apnea and were susceptible to high blood pressure, AFIB, and heart failure. Cardiologists find the home sleep device and improvement on the earlier CPAP in lab testing devices because they can focus on improving the health-related quality of life of their patient to expand their service portfolio with the inclusion of a speedy diagnosis and treatment for the condition of obstructive sleep apnea.
It is also an established fact that many patients suffering from this condition and advised to undergo a sleep study often ignored the advice of the cardiologist simply because of the drawbacks which we have mentioned earlier. Patients just did not want to go through the difficulties or the expenses and continued to ignore their condition despite being advised against it by their cardiologists.
Changes have been seen ever since the home sleep device was introduced. Presently patients only have to view the flyer about sleep apnea in the office of the cardiologist before they become prepared to take the test because of the ease at which the test can be completed. The home sleep device is certainly proving beneficial for preventive diagnosis of sleep apnea and at the same time giving cardiologists more reasons to utilize these devices before arriving at a decision.
This confirmation has also been provided by Dr. Randy Lieberman from Detroit who stated that patients only needed an explanation of how their quality of life can improve leading to better management of their cardiovascular disease component with the help of a home sleep device before they agreed to undergo the minimally invasive investigation in the comfort of their bed. Patients did not display any reluctance to undertake preventive diagnosis with the help of home sleep devices as compared to the earlier in lab sleep testing which they often tried to avoid.
The home sleep device does not require the patient to undergo testing in an environment they are accustomed to neither is it intrusive or causes any kind of discomfort. This is a tiny device which is strapped to the wrist of the patient for results to be obtained by the cardiologist who can provide the necessary treatment as required. This device is proving to be beneficial not just for patients but also for cardiologists and is perhaps the reason why it is being utilized for preventive diagnosis by some of the leading cardiologists throughout the globe.